Literature DB >> 16920950

Mutational analysis of the mechanism of negative regulation by SRC homology 2 domain-containing protein tyrosine phosphatase substrate-1 of phagocytosis in macrophages.

Hiroshi Ikeda1, Hideki Okazawa, Hiroshi Ohnishi, Yoji Murata, Per-Arne Oldenborg, Takashi Matozaki.   

Abstract

Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 (SHPS-1) is a transmembrane protein predominantly expressed in macrophages. The binding of CD47 on RBCs to SHPS-1 on macrophages is implicated in inhibition of phagocytosis of the former cells by the latter. We have now shown that forced expression in mouse RAW264.7 macrophages of a mutant version (SHPS-1-4F) of mouse SHPS-1, in which four tyrosine phosphorylation sites are replaced by phenylalanine, markedly promoted Fc gammaR-mediated phagocytosis of mouse RBCs or SRBCs. Forced expression of another mutant form (SHPS-1-deltaCyto) of mouse SHPS-1, which lacks most of the cytoplasmic region, did not promote such phagocytosis. Similarly, forced expression of a rat version of SHPS-1-4F, but not that of rat wild-type SHPS-1 or SHPS-1-deltaCyto, in RAW264.7 cells enhanced Fc gammaR-mediated phagocytosis of RBCs. Tyrosine phosphorylation of endogenous SHPS-1 as well as its association with Src homology 2 domain-containing protein tyrosine phosphatase-1 were not markedly inhibited by expression of SHPS-1-4F. Furthermore, the attachment of IgG-opsonized RBCs to RAW264.7 cells was markedly increased by expression of SHPS-1-4F, and this effect did not appear to be mediated by the interaction between CD47 and SHPS-1. These data suggest that inhibition by SHPS-1 of phagocytosis in macrophages is mediated, at least in part, in a manner independent of the transinteraction between CD47 and SHPS-1. In addition, the cytoplasmic region as well as tyrosine phosphorylation sites in this region of SHPS-1 appear indispensable for this inhibitory action of SHPS-1. Moreover, SHPS-1 may regulate the attachment of RBCs to macrophages by an as yet unidentified mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920950     DOI: 10.4049/jimmunol.177.5.3123

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

Review 1.  CD47: a new target in cardiovascular therapy.

Authors:  Jeff S Isenberg; David D Roberts; William A Frazier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-10       Impact factor: 8.311

2.  Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages.

Authors:  Zhiyuan Lv; Zhen Bian; Lei Shi; Shuo Niu; Binh Ha; Alexandra Tremblay; Liangwei Li; Xiugen Zhang; John Paluszynski; Ming Liu; Ke Zen; Yuan Liu
Journal:  J Immunol       Date:  2015-06-17       Impact factor: 5.422

3.  MicroRNA-17/20a/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein α.

Authors:  Dihan Zhu; Chaoyun Pan; Limin Li; Zhen Bian; Zhiyuan Lv; Lei Shi; Jing Zhang; Donghai Li; Hongwei Gu; Chen-Yu Zhang; Yuan Liu; Ke Zen
Journal:  J Allergy Clin Immunol       Date:  2013-04-04       Impact factor: 10.793

4.  'Clustering' SIRPα into the plasma membrane lipid microdomains is required for activated monocytes and macrophages to mediate effective cell surface interactions with CD47.

Authors:  Binh Ha; Zhiyuan Lv; Zhen Bian; Xiugen Zhang; Aarti Mishra; Yuan Liu
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.